Nalmefene hydrochloride

This classification denotes an opiate antagonist with the molecular formula C21H25NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K7K69QC05X, chemically known as 17-(cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-3,14-diol, , hydrochloride but more generally known as nalmefene hydrochloride, which bears US NIH Compound Identifier 5388881. European Medicines Agency schedules Nalmefene hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14628MIG. Most nations, for tariff and trade purposes, schedule nalmefene hydrochloride under HS 29391900 and SITC 54141. As of Q4 2014, NALMEFENE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Nalmefene hydrochloride bears US NLM identifiers UMLS ID C0771297 and NCI Concept Code C47631. SMILES: C=C1CC[C@]2([C@H]3CC4CCC(C5C4[C@]2([C@H]1O5)CCN3CC6CC6)O)O.CL.